Cargando…
Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy
Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disorder of the brain caused by reactivation of the JC virus (JCV), a polyomavirus that infects at least 60% of the population but is asymptomatic or results in benign symptoms in most people. PML occurs as a secondary disease...
Autores principales: | Eis, Peggy S., Bruno, Christopher D., Richmond, Todd A., Koralnik, Igor J., Hanson, Barbara A., Major, Eugene O., Chow, Christina R., Hendel-Chavez, Houria, Stankoff, Bruno, Gasnault, Jacques, Taoufik, Yassine, Hatchwell, Eli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094807/ https://www.ncbi.nlm.nih.gov/pubmed/32256442 http://dx.doi.org/10.3389/fneur.2020.00186 |
Ejemplares similares
-
Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
por: Hatchwell, Eli, et al.
Publicado: (2022) -
Efficacy of Recombinant Human Interleukin 7 in a Patient With Severe Lymphopenia-Related Progressive Multifocal Leukoencephalopathy
por: Gasnault, Jacques, et al.
Publicado: (2014) -
Refractory T-Cell Anergy and Rapidly Fatal Progressive Multifocal Leukoencephalopathy After Prolonged CTLA4 Therapy
por: Dekeyser, Manon, et al.
Publicado: (2017) -
B Cells and Progressive Multifocal Leukoencephalopathy: Search for the Missing Link
por: Durali, Deniz, et al.
Publicado: (2015) -
Improved Survival of HIV-1-Infected Patients with Progressive Multifocal Leukoencephalopathy Receiving Early 5-Drug Combination Antiretroviral Therapy
por: Gasnault, Jacques, et al.
Publicado: (2011)